ArticleCancer management and research2021

Real-World Analysis of the Efficacy and Safety of a Novel Irreversible HER2 Tyrosine Kinase Inhibitor Pyrotinib in Patients with HER2-Positive Metastatic Breast Cancer.

Ying Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.